Neurorehabilitation Devices - Comprehensive Study by Type (Nuro-robotic device, Non-invasive stimulator, Wearable devices, Brain-computer interface, Others), Application (Parkinson's disease, Bran trauma injury, Spinal cord injury, Stroke, Schizophrenia, Cerebral palsy, Others), End users (Hospitals/clinics, Research institution, Cognitive care centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Ecommerce) Players and Region - Global Market Outlook to 2028

Report Objectives / Segmentation Covered

• Nuro-robotic device
• Non-invasive stimulator
• Wearable devices
• Brain-computer interface
• Others

• Parkinson's disease
• Bran trauma injury
• Spinal cord injury
• Stroke
• Schizophrenia
• Cerebral palsy
• Others

• Hospitals/clinics
• Research institution
• Cognitive care centers
• Others

• Hospital Pharmacy
• Retail Pharmacies
• Ecommerce

• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • Italy
  • United Kingdom
  • Netherlands
  • Rest of Europe
• MEA
  • Middle East
  • Africa
• North America
  • United States
  • Canada
  • Mexico

• 1. Market Overview
  • 1.1. Introduction
  • 1.2. Scope/Objective of the Study
    • 1.2.1. Research Objective
• 2. Executive Summary
  • 2.1. Introduction
• 3. Market Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Neurorehabilitation devices also have a real potential to save patients money
  • 3.3. Market Challenges
    • 3.3.1. The government pays less attention to rehab services
  • 3.4. Market Trends
    • 3.4.1. Rising cases of neurological disorders and the availability of numerous approved devices
• 4. Market Factor Analysis
  • 4.1. Porters Five Forces
  • 4.2. Supply/Value Chain
  • 4.3. PESTEL analysis
  • 4.4. Market Entropy
  • 4.5. Patent/Trademark Analysis
• 5. Global Neurorehabilitation Devices -, by Type, Application, End users, Distribution Channel and Region (value, volume and price ) (2017-2022)
  • 5.1. Introduction
  • 5.2. Global Neurorehabilitation Devices - (Value)
    • 5.2.1. Global Neurorehabilitation Devices - by: Type (Value)
      • 5.2.1.1. Nuro-robotic device
      • 5.2.1.2. Non-invasive stimulator
      • 5.2.1.3. Wearable devices
      • 5.2.1.4. Brain-computer interface
      • 5.2.1.5. Others
    • 5.2.2. Global Neurorehabilitation Devices - by: Application (Value)
      • 5.2.2.1. Parkinson's disease
      • 5.2.2.2. Bran trauma injury
      • 5.2.2.3. Spinal cord injury
      • 5.2.2.4. Stroke
      • 5.2.2.5. Schizophrenia
      • 5.2.2.6. Cerebral palsy
      • 5.2.2.7. Others
    • 5.2.3. Global Neurorehabilitation Devices - by: End users (Value)
      • 5.2.3.1. Hospitals/clinics
      • 5.2.3.2. Research institution
      • 5.2.3.3. Cognitive care centers
      • 5.2.3.4. Others
    • 5.2.4. Global Neurorehabilitation Devices - by: Distribution Channel (Value)
      • 5.2.4.1. Hospital Pharmacy
      • 5.2.4.2. Retail Pharmacies
      • 5.2.4.3. Ecommerce
    • 5.2.5. Global Neurorehabilitation Devices - Region
      • 5.2.5.1. South America
        • 5.2.5.1.1. Brazil
        • 5.2.5.1.2. Argentina
        • 5.2.5.1.3. Rest of South America
      • 5.2.5.2. Asia Pacific
        • 5.2.5.2.1. China
        • 5.2.5.2.2. Japan
        • 5.2.5.2.3. India
        • 5.2.5.2.4. South Korea
        • 5.2.5.2.5. Taiwan
        • 5.2.5.2.6. Australia
        • 5.2.5.2.7. Rest of Asia-Pacific
      • 5.2.5.3. Europe
        • 5.2.5.3.1. Germany
        • 5.2.5.3.2. France
        • 5.2.5.3.3. Italy
        • 5.2.5.3.4. United Kingdom
        • 5.2.5.3.5. Netherlands
        • 5.2.5.3.6. Rest of Europe
      • 5.2.5.4. MEA
        • 5.2.5.4.1. Middle East
        • 5.2.5.4.2. Africa
      • 5.2.5.5. North America
        • 5.2.5.5.1. United States
        • 5.2.5.5.2. Canada
        • 5.2.5.5.3. Mexico
  • 5.3. Global Neurorehabilitation Devices - (Volume)
    • 5.3.1. Global Neurorehabilitation Devices - by: Type (Volume)
      • 5.3.1.1. Nuro-robotic device
      • 5.3.1.2. Non-invasive stimulator
      • 5.3.1.3. Wearable devices
      • 5.3.1.4. Brain-computer interface
      • 5.3.1.5. Others
    • 5.3.2. Global Neurorehabilitation Devices - by: Application (Volume)
      • 5.3.2.1. Parkinson's disease
      • 5.3.2.2. Bran trauma injury
      • 5.3.2.3. Spinal cord injury
      • 5.3.2.4. Stroke
      • 5.3.2.5. Schizophrenia
      • 5.3.2.6. Cerebral palsy
      • 5.3.2.7. Others
    • 5.3.3. Global Neurorehabilitation Devices - by: End users (Volume)
      • 5.3.3.1. Hospitals/clinics
      • 5.3.3.2. Research institution
      • 5.3.3.3. Cognitive care centers
      • 5.3.3.4. Others
    • 5.3.4. Global Neurorehabilitation Devices - by: Distribution Channel (Volume)
      • 5.3.4.1. Hospital Pharmacy
      • 5.3.4.2. Retail Pharmacies
      • 5.3.4.3. Ecommerce
    • 5.3.5. Global Neurorehabilitation Devices - Region
      • 5.3.5.1. South America
        • 5.3.5.1.1. Brazil
        • 5.3.5.1.2. Argentina
        • 5.3.5.1.3. Rest of South America
      • 5.3.5.2. Asia Pacific
        • 5.3.5.2.1. China
        • 5.3.5.2.2. Japan
        • 5.3.5.2.3. India
        • 5.3.5.2.4. South Korea
        • 5.3.5.2.5. Taiwan
        • 5.3.5.2.6. Australia
        • 5.3.5.2.7. Rest of Asia-Pacific
      • 5.3.5.3. Europe
        • 5.3.5.3.1. Germany
        • 5.3.5.3.2. France
        • 5.3.5.3.3. Italy
        • 5.3.5.3.4. United Kingdom
        • 5.3.5.3.5. Netherlands
        • 5.3.5.3.6. Rest of Europe
      • 5.3.5.4. MEA
        • 5.3.5.4.1. Middle East
        • 5.3.5.4.2. Africa
      • 5.3.5.5. North America
        • 5.3.5.5.1. United States
        • 5.3.5.5.2. Canada
        • 5.3.5.5.3. Mexico
  • 5.4. Global Neurorehabilitation Devices - (Price)
    • 5.4.1. Global Neurorehabilitation Devices - by: Type (Price)
• 6. Neurorehabilitation Devices -: Manufacturers/Players Analysis
  • 6.1. Competitive Landscape
    • 6.1.1. Market Share Analysis
      • 6.1.1.1. Top 3
      • 6.1.1.2. Top 5
  • 6.2. Peer Group Analysis (2022)
  • 6.3. BCG Matrix
  • 6.4. Company Profile
    • 6.4.1. NeuroPace, Inc. (United States)
      • 6.4.1.1. Business Overview
      • 6.4.1.2. Products/Services Offerings
      • 6.4.1.3. Financial Analysis
      • 6.4.1.4. SWOT Analysis
    • 6.4.2. Mindmaze (Switzerland)
      • 6.4.2.1. Business Overview
      • 6.4.2.2. Products/Services Offerings
      • 6.4.2.3. Financial Analysis
      • 6.4.2.4. SWOT Analysis
    • 6.4.3. Neuros Medical (United States)
      • 6.4.3.1. Business Overview
      • 6.4.3.2. Products/Services Offerings
      • 6.4.3.3. Financial Analysis
      • 6.4.3.4. SWOT Analysis
    • 6.4.4. Flow Neuroscience (Sweden)
      • 6.4.4.1. Business Overview
      • 6.4.4.2. Products/Services Offerings
      • 6.4.4.3. Financial Analysis
      • 6.4.4.4. SWOT Analysis
    • 6.4.5. NEURALINK (United States)
      • 6.4.5.1. Business Overview
      • 6.4.5.2. Products/Services Offerings
      • 6.4.5.3. Financial Analysis
      • 6.4.5.4. SWOT Analysis
    • 6.4.6. Hocona AG (Switzerland)
      • 6.4.6.1. Business Overview
      • 6.4.6.2. Products/Services Offerings
      • 6.4.6.3. Financial Analysis
      • 6.4.6.4. SWOT Analysis
    • 6.4.7. BrainCo, Inc. (United States)
      • 6.4.7.1. Business Overview
      • 6.4.7.2. Products/Services Offerings
      • 6.4.7.3. Financial Analysis
      • 6.4.7.4. SWOT Analysis
    • 6.4.8. Medtronic (Ireland)
      • 6.4.8.1. Business Overview
      • 6.4.8.2. Products/Services Offerings
      • 6.4.8.3. Financial Analysis
      • 6.4.8.4. SWOT Analysis
    • 6.4.9. Synchron (United States)
      • 6.4.9.1. Business Overview
      • 6.4.9.2. Products/Services Offerings
      • 6.4.9.3. Financial Analysis
      • 6.4.9.4. SWOT Analysis
    • 6.4.10. Halo Neuroscience (United States)
      • 6.4.10.1. Business Overview
      • 6.4.10.2. Products/Services Offerings
      • 6.4.10.3. Financial Analysis
      • 6.4.10.4. SWOT Analysis
    • 6.4.11. UsMIMA. (United States)
      • 6.4.11.1. Business Overview
      • 6.4.11.2. Products/Services Offerings
      • 6.4.11.3. Financial Analysis
      • 6.4.11.4. SWOT Analysis
• 7. Global Neurorehabilitation Devices - Sale, by Type, Application, End users, Distribution Channel and Region (value, volume and price ) (2023-2028)
  • 7.1. Introduction
  • 7.2. Global Neurorehabilitation Devices - (Value)
    • 7.2.1. Global Neurorehabilitation Devices - by: Type (Value)
      • 7.2.1.1. Nuro-robotic device
      • 7.2.1.2. Non-invasive stimulator
      • 7.2.1.3. Wearable devices
      • 7.2.1.4. Brain-computer interface
      • 7.2.1.5. Others
    • 7.2.2. Global Neurorehabilitation Devices - by: Application (Value)
      • 7.2.2.1. Parkinson's disease
      • 7.2.2.2. Bran trauma injury
      • 7.2.2.3. Spinal cord injury
      • 7.2.2.4. Stroke
      • 7.2.2.5. Schizophrenia
      • 7.2.2.6. Cerebral palsy
      • 7.2.2.7. Others
    • 7.2.3. Global Neurorehabilitation Devices - by: End users (Value)
      • 7.2.3.1. Hospitals/clinics
      • 7.2.3.2. Research institution
      • 7.2.3.3. Cognitive care centers
      • 7.2.3.4. Others
    • 7.2.4. Global Neurorehabilitation Devices - by: Distribution Channel (Value)
      • 7.2.4.1. Hospital Pharmacy
      • 7.2.4.2. Retail Pharmacies
      • 7.2.4.3. Ecommerce
    • 7.2.5. Global Neurorehabilitation Devices - Region
      • 7.2.5.1. South America
        • 7.2.5.1.1. Brazil
        • 7.2.5.1.2. Argentina
        • 7.2.5.1.3. Rest of South America
      • 7.2.5.2. Asia Pacific
        • 7.2.5.2.1. China
        • 7.2.5.2.2. Japan
        • 7.2.5.2.3. India
        • 7.2.5.2.4. South Korea
        • 7.2.5.2.5. Taiwan
        • 7.2.5.2.6. Australia
        • 7.2.5.2.7. Rest of Asia-Pacific
      • 7.2.5.3. Europe
        • 7.2.5.3.1. Germany
        • 7.2.5.3.2. France
        • 7.2.5.3.3. Italy
        • 7.2.5.3.4. United Kingdom
        • 7.2.5.3.5. Netherlands
        • 7.2.5.3.6. Rest of Europe
      • 7.2.5.4. MEA
        • 7.2.5.4.1. Middle East
        • 7.2.5.4.2. Africa
      • 7.2.5.5. North America
        • 7.2.5.5.1. United States
        • 7.2.5.5.2. Canada
        • 7.2.5.5.3. Mexico
  • 7.3. Global Neurorehabilitation Devices - (Volume)
    • 7.3.1. Global Neurorehabilitation Devices - by: Type (Volume)
      • 7.3.1.1. Nuro-robotic device
      • 7.3.1.2. Non-invasive stimulator
      • 7.3.1.3. Wearable devices
      • 7.3.1.4. Brain-computer interface
      • 7.3.1.5. Others
    • 7.3.2. Global Neurorehabilitation Devices - by: Application (Volume)
      • 7.3.2.1. Parkinson's disease
      • 7.3.2.2. Bran trauma injury
      • 7.3.2.3. Spinal cord injury
      • 7.3.2.4. Stroke
      • 7.3.2.5. Schizophrenia
      • 7.3.2.6. Cerebral palsy
      • 7.3.2.7. Others
    • 7.3.3. Global Neurorehabilitation Devices - by: End users (Volume)
      • 7.3.3.1. Hospitals/clinics
      • 7.3.3.2. Research institution
      • 7.3.3.3. Cognitive care centers
      • 7.3.3.4. Others
    • 7.3.4. Global Neurorehabilitation Devices - by: Distribution Channel (Volume)
      • 7.3.4.1. Hospital Pharmacy
      • 7.3.4.2. Retail Pharmacies
      • 7.3.4.3. Ecommerce
    • 7.3.5. Global Neurorehabilitation Devices - Region
      • 7.3.5.1. South America
        • 7.3.5.1.1. Brazil
        • 7.3.5.1.2. Argentina
        • 7.3.5.1.3. Rest of South America
      • 7.3.5.2. Asia Pacific
        • 7.3.5.2.1. China
        • 7.3.5.2.2. Japan
        • 7.3.5.2.3. India
        • 7.3.5.2.4. South Korea
        • 7.3.5.2.5. Taiwan
        • 7.3.5.2.6. Australia
        • 7.3.5.2.7. Rest of Asia-Pacific
      • 7.3.5.3. Europe
        • 7.3.5.3.1. Germany
        • 7.3.5.3.2. France
        • 7.3.5.3.3. Italy
        • 7.3.5.3.4. United Kingdom
        • 7.3.5.3.5. Netherlands
        • 7.3.5.3.6. Rest of Europe
      • 7.3.5.4. MEA
        • 7.3.5.4.1. Middle East
        • 7.3.5.4.2. Africa
      • 7.3.5.5. North America
        • 7.3.5.5.1. United States
        • 7.3.5.5.2. Canada
        • 7.3.5.5.3. Mexico
  • 7.4. Global Neurorehabilitation Devices - (Price)
    • 7.4.1. Global Neurorehabilitation Devices - by: Type (Price)
• 8. Appendix
  • 8.1. Acronyms
• 9. Methodology and Data Source
  • 9.1. Methodology/Research Approach
    • 9.1.1. Research Programs/Design
    • 9.1.2. Market Size Estimation
    • 9.1.3. Market Breakdown and Data Triangulation
  • 9.2. Data Source
    • 9.2.1. Secondary Sources
    • 9.2.2. Primary Sources
  • 9.3. Disclaimer

• Table 1. Neurorehabilitation Devices -: by Type(USD Million)
• Table 2. Neurorehabilitation Devices - Nuro-robotic device , by Region USD Million (2017-2022)
• Table 3. Neurorehabilitation Devices - Non-invasive stimulator , by Region USD Million (2017-2022)
• Table 4. Neurorehabilitation Devices - Wearable devices , by Region USD Million (2017-2022)
• Table 5. Neurorehabilitation Devices - Brain-computer interface , by Region USD Million (2017-2022)
• Table 6. Neurorehabilitation Devices - Others , by Region USD Million (2017-2022)
• Table 7. Neurorehabilitation Devices -: by Application(USD Million)
• Table 8. Neurorehabilitation Devices - Parkinson's disease , by Region USD Million (2017-2022)
• Table 9. Neurorehabilitation Devices - Bran trauma injury , by Region USD Million (2017-2022)
• Table 10. Neurorehabilitation Devices - Spinal cord injury , by Region USD Million (2017-2022)
• Table 11. Neurorehabilitation Devices - Stroke , by Region USD Million (2017-2022)
• Table 12. Neurorehabilitation Devices - Schizophrenia , by Region USD Million (2017-2022)
• Table 13. Neurorehabilitation Devices - Cerebral palsy , by Region USD Million (2017-2022)
• Table 14. Neurorehabilitation Devices - Others , by Region USD Million (2017-2022)
• Table 15. Neurorehabilitation Devices -: by End users(USD Million)
• Table 16. Neurorehabilitation Devices - Hospitals/clinics , by Region USD Million (2017-2022)
• Table 17. Neurorehabilitation Devices - Research institution , by Region USD Million (2017-2022)
• Table 18. Neurorehabilitation Devices - Cognitive care centers , by Region USD Million (2017-2022)
• Table 19. Neurorehabilitation Devices - Others , by Region USD Million (2017-2022)
• Table 20. Neurorehabilitation Devices -: by Distribution Channel(USD Million)
• Table 21. Neurorehabilitation Devices - Hospital Pharmacy , by Region USD Million (2017-2022)
• Table 22. Neurorehabilitation Devices - Retail Pharmacies , by Region USD Million (2017-2022)
• Table 23. Neurorehabilitation Devices - Ecommerce , by Region USD Million (2017-2022)
• Table 24. South America Neurorehabilitation Devices -, by Country USD Million (2017-2022)
• Table 25. South America Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 26. South America Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 27. South America Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 28. South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 29. Brazil Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 30. Brazil Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 31. Brazil Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 32. Brazil Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 33. Argentina Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 34. Argentina Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 35. Argentina Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 36. Argentina Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 37. Rest of South America Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 38. Rest of South America Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 39. Rest of South America Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 40. Rest of South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 41. Asia Pacific Neurorehabilitation Devices -, by Country USD Million (2017-2022)
• Table 42. Asia Pacific Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 43. Asia Pacific Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 44. Asia Pacific Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 45. Asia Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 46. China Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 47. China Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 48. China Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 49. China Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 50. Japan Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 51. Japan Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 52. Japan Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 53. Japan Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 54. India Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 55. India Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 56. India Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 57. India Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 58. South Korea Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 59. South Korea Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 60. South Korea Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 61. South Korea Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 62. Taiwan Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 63. Taiwan Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 64. Taiwan Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 65. Taiwan Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 66. Australia Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 67. Australia Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 68. Australia Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 69. Australia Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 70. Rest of Asia-Pacific Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 71. Rest of Asia-Pacific Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 72. Rest of Asia-Pacific Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 73. Rest of Asia-Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 74. Europe Neurorehabilitation Devices -, by Country USD Million (2017-2022)
• Table 75. Europe Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 76. Europe Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 77. Europe Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 78. Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 79. Germany Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 80. Germany Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 81. Germany Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 82. Germany Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 83. France Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 84. France Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 85. France Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 86. France Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 87. Italy Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 88. Italy Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 89. Italy Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 90. Italy Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 91. United Kingdom Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 92. United Kingdom Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 93. United Kingdom Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 94. United Kingdom Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 95. Netherlands Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 96. Netherlands Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 97. Netherlands Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 98. Netherlands Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 99. Rest of Europe Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 100. Rest of Europe Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 101. Rest of Europe Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 102. Rest of Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 103. MEA Neurorehabilitation Devices -, by Country USD Million (2017-2022)
• Table 104. MEA Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 105. MEA Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 106. MEA Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 107. MEA Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 108. Middle East Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 109. Middle East Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 110. Middle East Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 111. Middle East Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 112. Africa Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 113. Africa Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 114. Africa Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 115. Africa Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 116. North America Neurorehabilitation Devices -, by Country USD Million (2017-2022)
• Table 117. North America Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 118. North America Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 119. North America Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 120. North America Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 121. United States Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 122. United States Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 123. United States Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 124. United States Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 125. Canada Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 126. Canada Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 127. Canada Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 128. Canada Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 129. Mexico Neurorehabilitation Devices -, by Type USD Million (2017-2022)
• Table 130. Mexico Neurorehabilitation Devices -, by Application USD Million (2017-2022)
• Table 131. Mexico Neurorehabilitation Devices -, by End users USD Million (2017-2022)
• Table 132. Mexico Neurorehabilitation Devices -, by Distribution Channel USD Million (2017-2022)
• Table 133. Neurorehabilitation Devices - Sales: by Type(K Units)
• Table 134. Neurorehabilitation Devices - Sales Nuro-robotic device , by Region K Units (2017-2022)
• Table 135. Neurorehabilitation Devices - Sales Non-invasive stimulator , by Region K Units (2017-2022)
• Table 136. Neurorehabilitation Devices - Sales Wearable devices , by Region K Units (2017-2022)
• Table 137. Neurorehabilitation Devices - Sales Brain-computer interface , by Region K Units (2017-2022)
• Table 138. Neurorehabilitation Devices - Sales Others , by Region K Units (2017-2022)
• Table 139. Neurorehabilitation Devices - Sales: by Application(K Units)
• Table 140. Neurorehabilitation Devices - Sales Parkinson's disease , by Region K Units (2017-2022)
• Table 141. Neurorehabilitation Devices - Sales Bran trauma injury , by Region K Units (2017-2022)
• Table 142. Neurorehabilitation Devices - Sales Spinal cord injury , by Region K Units (2017-2022)
• Table 143. Neurorehabilitation Devices - Sales Stroke , by Region K Units (2017-2022)
• Table 144. Neurorehabilitation Devices - Sales Schizophrenia , by Region K Units (2017-2022)
• Table 145. Neurorehabilitation Devices - Sales Cerebral palsy , by Region K Units (2017-2022)
• Table 146. Neurorehabilitation Devices - Sales Others , by Region K Units (2017-2022)
• Table 147. Neurorehabilitation Devices - Sales: by End users(K Units)
• Table 148. Neurorehabilitation Devices - Sales Hospitals/clinics , by Region K Units (2017-2022)
• Table 149. Neurorehabilitation Devices - Sales Research institution , by Region K Units (2017-2022)
• Table 150. Neurorehabilitation Devices - Sales Cognitive care centers , by Region K Units (2017-2022)
• Table 151. Neurorehabilitation Devices - Sales Others , by Region K Units (2017-2022)
• Table 152. Neurorehabilitation Devices - Sales: by Distribution Channel(K Units)
• Table 153. Neurorehabilitation Devices - Sales Hospital Pharmacy , by Region K Units (2017-2022)
• Table 154. Neurorehabilitation Devices - Sales Retail Pharmacies , by Region K Units (2017-2022)
• Table 155. Neurorehabilitation Devices - Sales Ecommerce , by Region K Units (2017-2022)
• Table 156. South America Neurorehabilitation Devices - Sales, by Country K Units (2017-2022)
• Table 157. South America Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 158. South America Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 159. South America Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 160. South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 161. Brazil Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 162. Brazil Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 163. Brazil Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 164. Brazil Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 165. Argentina Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 166. Argentina Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 167. Argentina Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 168. Argentina Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 169. Rest of South America Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 170. Rest of South America Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 171. Rest of South America Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 172. Rest of South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 173. Asia Pacific Neurorehabilitation Devices - Sales, by Country K Units (2017-2022)
• Table 174. Asia Pacific Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 175. Asia Pacific Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 176. Asia Pacific Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 177. Asia Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 178. China Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 179. China Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 180. China Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 181. China Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 182. Japan Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 183. Japan Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 184. Japan Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 185. Japan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 186. India Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 187. India Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 188. India Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 189. India Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 190. South Korea Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 191. South Korea Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 192. South Korea Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 193. South Korea Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 194. Taiwan Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 195. Taiwan Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 196. Taiwan Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 197. Taiwan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 198. Australia Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 199. Australia Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 200. Australia Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 201. Australia Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 202. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 203. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 204. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 205. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 206. Europe Neurorehabilitation Devices - Sales, by Country K Units (2017-2022)
• Table 207. Europe Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 208. Europe Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 209. Europe Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 210. Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 211. Germany Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 212. Germany Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 213. Germany Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 214. Germany Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 215. France Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 216. France Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 217. France Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 218. France Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 219. Italy Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 220. Italy Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 221. Italy Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 222. Italy Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 223. United Kingdom Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 224. United Kingdom Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 225. United Kingdom Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 226. United Kingdom Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 227. Netherlands Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 228. Netherlands Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 229. Netherlands Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 230. Netherlands Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 231. Rest of Europe Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 232. Rest of Europe Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 233. Rest of Europe Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 234. Rest of Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 235. MEA Neurorehabilitation Devices - Sales, by Country K Units (2017-2022)
• Table 236. MEA Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 237. MEA Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 238. MEA Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 239. MEA Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 240. Middle East Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 241. Middle East Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 242. Middle East Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 243. Middle East Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 244. Africa Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 245. Africa Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 246. Africa Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 247. Africa Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 248. North America Neurorehabilitation Devices - Sales, by Country K Units (2017-2022)
• Table 249. North America Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 250. North America Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 251. North America Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 252. North America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 253. United States Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 254. United States Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 255. United States Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 256. United States Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 257. Canada Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 258. Canada Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 259. Canada Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 260. Canada Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 261. Mexico Neurorehabilitation Devices - Sales, by Type K Units (2017-2022)
• Table 262. Mexico Neurorehabilitation Devices - Sales, by Application K Units (2017-2022)
• Table 263. Mexico Neurorehabilitation Devices - Sales, by End users K Units (2017-2022)
• Table 264. Mexico Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2017-2022)
• Table 265. Neurorehabilitation Devices -: by Type(USD/Units)
• Table 266. Company Basic Information, Sales Area and Its Competitors
• Table 267. Company Basic Information, Sales Area and Its Competitors
• Table 268. Company Basic Information, Sales Area and Its Competitors
• Table 269. Company Basic Information, Sales Area and Its Competitors
• Table 270. Company Basic Information, Sales Area and Its Competitors
• Table 271. Company Basic Information, Sales Area and Its Competitors
• Table 272. Company Basic Information, Sales Area and Its Competitors
• Table 273. Company Basic Information, Sales Area and Its Competitors
• Table 274. Company Basic Information, Sales Area and Its Competitors
• Table 275. Company Basic Information, Sales Area and Its Competitors
• Table 276. Company Basic Information, Sales Area and Its Competitors
• Table 277. Neurorehabilitation Devices -: by Type(USD Million)
• Table 278. Neurorehabilitation Devices - Nuro-robotic device , by Region USD Million (2023-2028)
• Table 279. Neurorehabilitation Devices - Non-invasive stimulator , by Region USD Million (2023-2028)
• Table 280. Neurorehabilitation Devices - Wearable devices , by Region USD Million (2023-2028)
• Table 281. Neurorehabilitation Devices - Brain-computer interface , by Region USD Million (2023-2028)
• Table 282. Neurorehabilitation Devices - Others , by Region USD Million (2023-2028)
• Table 283. Neurorehabilitation Devices -: by Application(USD Million)
• Table 284. Neurorehabilitation Devices - Parkinson's disease , by Region USD Million (2023-2028)
• Table 285. Neurorehabilitation Devices - Bran trauma injury , by Region USD Million (2023-2028)
• Table 286. Neurorehabilitation Devices - Spinal cord injury , by Region USD Million (2023-2028)
• Table 287. Neurorehabilitation Devices - Stroke , by Region USD Million (2023-2028)
• Table 288. Neurorehabilitation Devices - Schizophrenia , by Region USD Million (2023-2028)
• Table 289. Neurorehabilitation Devices - Cerebral palsy , by Region USD Million (2023-2028)
• Table 290. Neurorehabilitation Devices - Others , by Region USD Million (2023-2028)
• Table 291. Neurorehabilitation Devices -: by End users(USD Million)
• Table 292. Neurorehabilitation Devices - Hospitals/clinics , by Region USD Million (2023-2028)
• Table 293. Neurorehabilitation Devices - Research institution , by Region USD Million (2023-2028)
• Table 294. Neurorehabilitation Devices - Cognitive care centers , by Region USD Million (2023-2028)
• Table 295. Neurorehabilitation Devices - Others , by Region USD Million (2023-2028)
• Table 296. Neurorehabilitation Devices -: by Distribution Channel(USD Million)
• Table 297. Neurorehabilitation Devices - Hospital Pharmacy , by Region USD Million (2023-2028)
• Table 298. Neurorehabilitation Devices - Retail Pharmacies , by Region USD Million (2023-2028)
• Table 299. Neurorehabilitation Devices - Ecommerce , by Region USD Million (2023-2028)
• Table 300. South America Neurorehabilitation Devices -, by Country USD Million (2023-2028)
• Table 301. South America Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 302. South America Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 303. South America Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 304. South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 305. Brazil Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 306. Brazil Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 307. Brazil Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 308. Brazil Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 309. Argentina Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 310. Argentina Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 311. Argentina Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 312. Argentina Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 313. Rest of South America Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 314. Rest of South America Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 315. Rest of South America Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 316. Rest of South America Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 317. Asia Pacific Neurorehabilitation Devices -, by Country USD Million (2023-2028)
• Table 318. Asia Pacific Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 319. Asia Pacific Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 320. Asia Pacific Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 321. Asia Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 322. China Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 323. China Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 324. China Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 325. China Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 326. Japan Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 327. Japan Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 328. Japan Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 329. Japan Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 330. India Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 331. India Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 332. India Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 333. India Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 334. South Korea Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 335. South Korea Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 336. South Korea Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 337. South Korea Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 338. Taiwan Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 339. Taiwan Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 340. Taiwan Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 341. Taiwan Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 342. Australia Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 343. Australia Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 344. Australia Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 345. Australia Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 346. Rest of Asia-Pacific Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 347. Rest of Asia-Pacific Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 348. Rest of Asia-Pacific Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 349. Rest of Asia-Pacific Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 350. Europe Neurorehabilitation Devices -, by Country USD Million (2023-2028)
• Table 351. Europe Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 352. Europe Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 353. Europe Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 354. Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 355. Germany Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 356. Germany Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 357. Germany Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 358. Germany Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 359. France Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 360. France Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 361. France Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 362. France Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 363. Italy Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 364. Italy Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 365. Italy Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 366. Italy Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 367. United Kingdom Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 368. United Kingdom Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 369. United Kingdom Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 370. United Kingdom Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 371. Netherlands Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 372. Netherlands Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 373. Netherlands Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 374. Netherlands Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 375. Rest of Europe Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 376. Rest of Europe Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 377. Rest of Europe Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 378. Rest of Europe Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 379. MEA Neurorehabilitation Devices -, by Country USD Million (2023-2028)
• Table 380. MEA Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 381. MEA Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 382. MEA Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 383. MEA Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 384. Middle East Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 385. Middle East Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 386. Middle East Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 387. Middle East Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 388. Africa Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 389. Africa Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 390. Africa Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 391. Africa Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 392. North America Neurorehabilitation Devices -, by Country USD Million (2023-2028)
• Table 393. North America Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 394. North America Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 395. North America Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 396. North America Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 397. United States Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 398. United States Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 399. United States Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 400. United States Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 401. Canada Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 402. Canada Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 403. Canada Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 404. Canada Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 405. Mexico Neurorehabilitation Devices -, by Type USD Million (2023-2028)
• Table 406. Mexico Neurorehabilitation Devices -, by Application USD Million (2023-2028)
• Table 407. Mexico Neurorehabilitation Devices -, by End users USD Million (2023-2028)
• Table 408. Mexico Neurorehabilitation Devices -, by Distribution Channel USD Million (2023-2028)
• Table 409. Neurorehabilitation Devices - Sales: by Type(K Units)
• Table 410. Neurorehabilitation Devices - Sales Nuro-robotic device , by Region K Units (2023-2028)
• Table 411. Neurorehabilitation Devices - Sales Non-invasive stimulator , by Region K Units (2023-2028)
• Table 412. Neurorehabilitation Devices - Sales Wearable devices , by Region K Units (2023-2028)
• Table 413. Neurorehabilitation Devices - Sales Brain-computer interface , by Region K Units (2023-2028)
• Table 414. Neurorehabilitation Devices - Sales Others , by Region K Units (2023-2028)
• Table 415. Neurorehabilitation Devices - Sales: by Application(K Units)
• Table 416. Neurorehabilitation Devices - Sales Parkinson's disease , by Region K Units (2023-2028)
• Table 417. Neurorehabilitation Devices - Sales Bran trauma injury , by Region K Units (2023-2028)
• Table 418. Neurorehabilitation Devices - Sales Spinal cord injury , by Region K Units (2023-2028)
• Table 419. Neurorehabilitation Devices - Sales Stroke , by Region K Units (2023-2028)
• Table 420. Neurorehabilitation Devices - Sales Schizophrenia , by Region K Units (2023-2028)
• Table 421. Neurorehabilitation Devices - Sales Cerebral palsy , by Region K Units (2023-2028)
• Table 422. Neurorehabilitation Devices - Sales Others , by Region K Units (2023-2028)
• Table 423. Neurorehabilitation Devices - Sales: by End users(K Units)
• Table 424. Neurorehabilitation Devices - Sales Hospitals/clinics , by Region K Units (2023-2028)
• Table 425. Neurorehabilitation Devices - Sales Research institution , by Region K Units (2023-2028)
• Table 426. Neurorehabilitation Devices - Sales Cognitive care centers , by Region K Units (2023-2028)
• Table 427. Neurorehabilitation Devices - Sales Others , by Region K Units (2023-2028)
• Table 428. Neurorehabilitation Devices - Sales: by Distribution Channel(K Units)
• Table 429. Neurorehabilitation Devices - Sales Hospital Pharmacy , by Region K Units (2023-2028)
• Table 430. Neurorehabilitation Devices - Sales Retail Pharmacies , by Region K Units (2023-2028)
• Table 431. Neurorehabilitation Devices - Sales Ecommerce , by Region K Units (2023-2028)
• Table 432. South America Neurorehabilitation Devices - Sales, by Country K Units (2023-2028)
• Table 433. South America Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 434. South America Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 435. South America Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 436. South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 437. Brazil Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 438. Brazil Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 439. Brazil Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 440. Brazil Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 441. Argentina Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 442. Argentina Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 443. Argentina Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 444. Argentina Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 445. Rest of South America Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 446. Rest of South America Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 447. Rest of South America Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 448. Rest of South America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 449. Asia Pacific Neurorehabilitation Devices - Sales, by Country K Units (2023-2028)
• Table 450. Asia Pacific Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 451. Asia Pacific Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 452. Asia Pacific Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 453. Asia Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 454. China Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 455. China Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 456. China Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 457. China Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 458. Japan Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 459. Japan Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 460. Japan Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 461. Japan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 462. India Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 463. India Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 464. India Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 465. India Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 466. South Korea Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 467. South Korea Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 468. South Korea Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 469. South Korea Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 470. Taiwan Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 471. Taiwan Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 472. Taiwan Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 473. Taiwan Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 474. Australia Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 475. Australia Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 476. Australia Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 477. Australia Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 478. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 479. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 480. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 481. Rest of Asia-Pacific Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 482. Europe Neurorehabilitation Devices - Sales, by Country K Units (2023-2028)
• Table 483. Europe Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 484. Europe Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 485. Europe Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 486. Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 487. Germany Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 488. Germany Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 489. Germany Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 490. Germany Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 491. France Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 492. France Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 493. France Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 494. France Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 495. Italy Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 496. Italy Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 497. Italy Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 498. Italy Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 499. United Kingdom Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 500. United Kingdom Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 501. United Kingdom Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 502. United Kingdom Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 503. Netherlands Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 504. Netherlands Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 505. Netherlands Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 506. Netherlands Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 507. Rest of Europe Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 508. Rest of Europe Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 509. Rest of Europe Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 510. Rest of Europe Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 511. MEA Neurorehabilitation Devices - Sales, by Country K Units (2023-2028)
• Table 512. MEA Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 513. MEA Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 514. MEA Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 515. MEA Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 516. Middle East Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 517. Middle East Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 518. Middle East Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 519. Middle East Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 520. Africa Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 521. Africa Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 522. Africa Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 523. Africa Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 524. North America Neurorehabilitation Devices - Sales, by Country K Units (2023-2028)
• Table 525. North America Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 526. North America Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 527. North America Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 528. North America Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 529. United States Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 530. United States Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 531. United States Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 532. United States Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 533. Canada Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 534. Canada Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 535. Canada Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 536. Canada Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 537. Mexico Neurorehabilitation Devices - Sales, by Type K Units (2023-2028)
• Table 538. Mexico Neurorehabilitation Devices - Sales, by Application K Units (2023-2028)
• Table 539. Mexico Neurorehabilitation Devices - Sales, by End users K Units (2023-2028)
• Table 540. Mexico Neurorehabilitation Devices - Sales, by Distribution Channel K Units (2023-2028)
• Table 541. Neurorehabilitation Devices -: by Type(USD/Units)
• Table 542. Research Programs/Design for This Report
• Table 543. Key Data Information from Secondary Sources
• Table 544. Key Data Information from Primary Sources

• Figure 1. Porters Five Forces
• Figure 2. Supply/Value Chain
• Figure 3. PESTEL analysis
• Figure 4. Global Neurorehabilitation Devices -: by Type USD Million (2017-2022)
• Figure 5. Global Neurorehabilitation Devices -: by Application USD Million (2017-2022)
• Figure 6. Global Neurorehabilitation Devices -: by End users USD Million (2017-2022)
• Figure 7. Global Neurorehabilitation Devices -: by Distribution Channel USD Million (2017-2022)
• Figure 8. South America Neurorehabilitation Devices - Share (%), by Country
• Figure 9. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
• Figure 10. Europe Neurorehabilitation Devices - Share (%), by Country
• Figure 11. MEA Neurorehabilitation Devices - Share (%), by Country
• Figure 12. North America Neurorehabilitation Devices - Share (%), by Country
• Figure 13. Global Neurorehabilitation Devices -: by Type K Units (2017-2022)
• Figure 14. Global Neurorehabilitation Devices -: by Application K Units (2017-2022)
• Figure 15. Global Neurorehabilitation Devices -: by End users K Units (2017-2022)
• Figure 16. Global Neurorehabilitation Devices -: by Distribution Channel K Units (2017-2022)
• Figure 17. South America Neurorehabilitation Devices - Share (%), by Country
• Figure 18. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
• Figure 19. Europe Neurorehabilitation Devices - Share (%), by Country
• Figure 20. MEA Neurorehabilitation Devices - Share (%), by Country
• Figure 21. North America Neurorehabilitation Devices - Share (%), by Country
• Figure 22. Global Neurorehabilitation Devices -: by Type USD/Units (2017-2022)
• Figure 23. Global Neurorehabilitation Devices - share by Players 2022 (%)
• Figure 24. Global Neurorehabilitation Devices - share by Players (Top 3) 2022(%)
• Figure 25. Global Neurorehabilitation Devices - share by Players (Top 5) 2022(%)
• Figure 26. BCG Matrix for key Companies
• Figure 27. NeuroPace, Inc. (United States) Revenue, Net Income and Gross profit
• Figure 28. NeuroPace, Inc. (United States) Revenue: by Geography 2022
• Figure 29. Mindmaze (Switzerland) Revenue, Net Income and Gross profit
• Figure 30. Mindmaze (Switzerland) Revenue: by Geography 2022
• Figure 31. Neuros Medical (United States) Revenue, Net Income and Gross profit
• Figure 32. Neuros Medical (United States) Revenue: by Geography 2022
• Figure 33. Flow Neuroscience (Sweden) Revenue, Net Income and Gross profit
• Figure 34. Flow Neuroscience (Sweden) Revenue: by Geography 2022
• Figure 35. NEURALINK (United States) Revenue, Net Income and Gross profit
• Figure 36. NEURALINK (United States) Revenue: by Geography 2022
• Figure 37. Hocona AG (Switzerland) Revenue, Net Income and Gross profit
• Figure 38. Hocona AG (Switzerland) Revenue: by Geography 2022
• Figure 39. BrainCo, Inc. (United States) Revenue, Net Income and Gross profit
• Figure 40. BrainCo, Inc. (United States) Revenue: by Geography 2022
• Figure 41. Medtronic (Ireland) Revenue, Net Income and Gross profit
• Figure 42. Medtronic (Ireland) Revenue: by Geography 2022
• Figure 43. Synchron (United States) Revenue, Net Income and Gross profit
• Figure 44. Synchron (United States) Revenue: by Geography 2022
• Figure 45. Halo Neuroscience (United States) Revenue, Net Income and Gross profit
• Figure 46. Halo Neuroscience (United States) Revenue: by Geography 2022
• Figure 47. UsMIMA. (United States) Revenue, Net Income and Gross profit
• Figure 48. UsMIMA. (United States) Revenue: by Geography 2022
• Figure 49. Global Neurorehabilitation Devices -: by Type USD Million (2023-2028)
• Figure 50. Global Neurorehabilitation Devices -: by Application USD Million (2023-2028)
• Figure 51. Global Neurorehabilitation Devices -: by End users USD Million (2023-2028)
• Figure 52. Global Neurorehabilitation Devices -: by Distribution Channel USD Million (2023-2028)
• Figure 53. South America Neurorehabilitation Devices - Share (%), by Country
• Figure 54. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
• Figure 55. Europe Neurorehabilitation Devices - Share (%), by Country
• Figure 56. MEA Neurorehabilitation Devices - Share (%), by Country
• Figure 57. North America Neurorehabilitation Devices - Share (%), by Country
• Figure 58. Global Neurorehabilitation Devices -: by Type K Units (2023-2028)
• Figure 59. Global Neurorehabilitation Devices -: by Application K Units (2023-2028)
• Figure 60. Global Neurorehabilitation Devices -: by End users K Units (2023-2028)
• Figure 61. Global Neurorehabilitation Devices -: by Distribution Channel K Units (2023-2028)
• Figure 62. South America Neurorehabilitation Devices - Share (%), by Country
• Figure 63. Asia Pacific Neurorehabilitation Devices - Share (%), by Country
• Figure 64. Europe Neurorehabilitation Devices - Share (%), by Country
• Figure 65. MEA Neurorehabilitation Devices - Share (%), by Country
• Figure 66. North America Neurorehabilitation Devices - Share (%), by Country
• Figure 67. Global Neurorehabilitation Devices -: by Type USD/Units (2023-2028)

• NeuroPace, Inc. (United States)
• Mindmaze (Switzerland)
• Neuros Medical (United States)
• Flow Neuroscience (Sweden)
• NEURALINK (United States)
• Hocona AG (Switzerland)
• BrainCo, Inc. (United States)
• Medtronic (Ireland)
• Synchron (United States)
• Halo Neuroscience (United States)
• usMIMA. (United States)